1. Intramacrophage potential of a tetrahydropyridine: A promising compound in combating Mycobacterium tuberculosis
- Author
-
Priscila Cristina Bartolomeu Halicki, Isabel Ladeira Pereira, Nilo Zanatta, Valquíria Pereira de Andrade, Pedro Eduardo Almeida da Silva, and Daniela Fernandes Ramos
- Subjects
Microbiology (medical) ,Pyrrolidines ,Infectious Diseases ,Immunology ,Antitubercular Agents ,Humans ,Microbial Sensitivity Tests ,Mycobacterium tuberculosis ,Rifampin ,Tuberculosis, Lymph Node ,Microbiology - Abstract
Due to several obstacles in treating tuberculosis (TB), the search for new therapeutic alternatives remains a global priority. The nitrogenous heterocyclic compounds are promising in searching for new anti-Mycobacterium tuberculosis molecules, and our previous results highlight the potential of tetrahydropyridines. After exploring the antimycobacterial potential and putative mechanism of action of a tetrahydropyridine derivative (NUNL02), we seek to measure the oxidative stress caused by NUNL02 inside the extracellular replicating M. tuberculosis since it could be the reason for the NUNL02 bactericidal effect against replicating and starved M. tuberculosis; and to evaluate the anti-M. tuberculosis activity of NUNL02 against the intracellular bacillus (even combined with an anti-TB drug) to explore the potential of this tetrahydropyridine as a promising adjuvant for TB therapy. Briefly, we assessed the activity of NUNL02 against the H
- Published
- 2022